alanine and baricitinib

alanine has been researched along with baricitinib in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's17 (100.00)2.80

Authors

AuthorsStudies
Barlow, A; Barlow, B; Claassen, CW; Heavner, JJ; Heavner, MS; Landolf, KM; Yeung, SYA1
Magro, G1
Ahuja, N; Amin, AN; Arguinchona, H; Beigel, JH; Billings, J; Bonnett, T; Branche, AR; Burgess, TH; Cantos, VD; Cardoso, A; Cohen, SH; Davey, RT; de Bono, S; Dempsey, W; Deye, GA; Dodd, LE; El Sahly, HM; Elie, MC; Engemann, JJ; Erdmann, N; Ferreira, J; Finberg, RW; Frank, M; Ghazaryan, V; Green, M; Hsieh, L; Iovine, NM; Jackson, PEH; Jain, MK; Kalil, AC; Kim, ES; Kline, S; Ko, ER; Larson, L; Luetkemeyer, AF; Lye, DC; Makowski, M; Marconi, VC; Mehta, AK; Mularski, RA; Nayak, SU; Nielsen, H; Oh, MD; Patterson, TF; Paules, CI; Ponce, PO; Proschan, M; Regalado Pineda, J; Rouphael, NG; Ruiz-Palacios, GM; Saklawi, Y; Sandkovsky, U; Sweeney, DA; Taiwo, B; Tan, SY; Tapson, V; Taylor, BS; Tomashek, KM; Watanabe, M; Wolfe, CR1
Wen, S; Xu, X; Yadav, AK; Yu, L1
Li, CC; Li, J; Liu, HH; Wang, J; Yin, XD1
Cantini, F; Goletti, D1
Hastings, R; Jha, R; Kumar, P; Quek, E; Tahir, H1
Awano, N; Fujimoto, K; Inomata, M; Ito, Y; Izumo, T; Kuse, N; Matsumoto, H; Muto, Y; Saiki, A; Sakamoto, K; Takada, K; Tone, M1
Adams, DH; Alatorre-Alexander, J; Cardoso, A; Chakladar, S; Crowe, B; de Bono, S; de Cassia Pellegrini, R; Ely, EW; Estrada, V; Goldman, JD; Kartman, CE; Krishnan, V; Liao, R; Marconi, VC; Piruzeli, MLB; Ramanan, AV; Reis, P; Som, M; Zhang, X1
Ferrara, F; Vitiello, A2
Belger, M; Burge, R; Hille, E; Kelton, K; Klein, T; McCollam, PL; Murphy, D; Spiro, T1
Arasawa, S; Hirayama, Y; Iwashima, D; Takahashi, KI; Uemasu, K; Yasuda, Y1
Banerjee, D; Das, D; Mukhopadhyay, P1
Horii, H; Kamada, K; Kojima, Y; Konno, S; Matsumoto, M; Nakakubo, S; Nakamura, J; Sato, K; Shima, H; Suzuki, M; Takei, N; Yamashita, Y1
Rochwerg, B; Tran, A1

Reviews

6 review(s) available for alanine and baricitinib

ArticleYear
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
    Pharmacotherapy, 2020, Volume: 40, Issue:5

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunomodulation; Interferon-alpha; Lopinavir; Nelfinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ribavirin; Ritonavir; SARS-CoV-2; Sulfonamides; Thiazoles

2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking.
    Virus research, 2020, Volume: 286

    Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides

2020
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
    Annals of palliative medicine, 2021, Volume: 10, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles

2021
COVID-19 illness and autoimmune diseases: recent insights.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2021, Volume: 70, Issue:4

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Arthritis, Rheumatoid; Autoimmune Diseases; Azetidines; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dendritic Cells; Humans; Immune System; Immunity, Innate; Immunization, Passive; Inflammatory Bowel Diseases; Killer Cells, Natural; Lupus Erythematosus, Systemic; Monocytes; Multiple Sclerosis; Purines; Pyrazoles; Sulfonamides

2021
Treatment of COVID-19: a review of current and prospective pharmacotherapies.
    British journal of hospital medicine (London, England : 2005), 2021, Mar-02, Volume: 82, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiviral Agents; Azetidines; Colchicine; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Dexamethasone; Glucocorticoids; Humans; Immunization, Passive; Immunologic Factors; Ivermectin; Janus Kinase Inhibitors; Platelet Aggregation Inhibitors; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides

2021
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection.
    Naunyn-Schmiedeberg's archives of pharmacology, 2022, Volume: 395, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Azetidines; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; Disease Management; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Humans; Purines; Pyrazoles; Sulfonamides

2022

Trials

3 trial(s) available for alanine and baricitinib

ArticleYear
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
    The New England journal of medicine, 2021, 03-04, Volume: 384, Issue:9

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Drug Therapy, Combination; Female; Hospital Mortality; Hospitalization; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Oxygen Inhalation Therapy; Purines; Pyrazoles; Respiration, Artificial; Sulfonamides; Treatment Outcome

2021
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial.
    The Lancet. Respiratory medicine, 2021, Volume: 9, Issue:12

    Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antiviral Agents; Asia; Azetidines; COVID-19 Drug Treatment; Dexamethasone; Double-Blind Method; Europe; Humans; North America; Purines; Pyrazoles; SARS-CoV-2; South America; Sulfonamides; Treatment Outcome

2021
In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival.
    Annals of internal medicine, 2022, Volume: 175, Issue:10

    Topics: Adenosine Monophosphate; Adult; Alanine; Azetidines; COVID-19 Drug Treatment; Dexamethasone; Double-Blind Method; Humans; Purines; Pyrazoles; Sulfonamides

2022

Other Studies

8 other study(ies) available for alanine and baricitinib

ArticleYear
An EUA for baricitinib (Olumiant) for COVID-19.
    The Medical letter on drugs and therapeutics, 2020, 12-28, Volume: 62, Issue:1614

    Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Antiviral Agents; Azetidines; Child; COVID-19 Drug Treatment; Drug Approval; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Randomized Controlled Trials as Topic; Sulfonamides; United States; United States Food and Drug Administration

2020
Baricitinib Therapy in Covid-19 Pneumonia - An Unmet Need Fulfilled.
    The New England journal of medicine, 2021, 03-04, Volume: 384, Issue:9

    Topics: Adenosine Monophosphate; Adult; Alanine; Azetidines; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; SARS-CoV-2; Sulfonamides

2021
Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.
    Respiratory investigation, 2021, Volume: 59, Issue:6

    Topics: Adenosine Monophosphate; Aged; Alanine; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Purines; Pyrazoles; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Treatment Outcome

2021
Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study.
    Advances in therapy, 2022, Volume: 39, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Azetidines; Cost-Benefit Analysis; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; Quality-Adjusted Life Years; SARS-CoV-2; Sulfonamides; United States

2022
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection.
    Molecular biology reports, 2022, Volume: 49, Issue:1

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Humans; Immunologic Factors; Pandemics; Purines; Pyrazoles; Sulfonamides

2022
Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study.
    Respiratory medicine and research, 2022, Volume: 81

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Humans; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides

2022
Mortality comparision in patients receiving either Remdesivir or Remdesivir plus Baricitinib combination in case of moderate to severe COVID-19 Pneumonia: A retrospective study.
    The Journal of the Association of Physicians of India, 2022, Volume: 70, Issue:4

    Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Humans; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides

2022
Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Humans; Immunologic Factors; Oxygen; Purines; Pyrazoles; Retrospective Studies; SARS-CoV-2; Sulfonamides

2022